Monday, November 19, 2018 Last Updated 0 Min 21 Sec ago Malayalam Edition
Todays E paper
Ads by Google
Thursday 02 Nov 2017 12.55 PM

Startup gets FDA clearance for device to treat newborn jaundice

start up, FDA clearance, newborn jaundice

NeoLight, an Arizona State University spinout that engineers, designs and manufactures technologies to treat infants with life-threatening medical conditions, announced it had received FDA clearance to market Skylife, a portable phototherapy system.

NeoLight, located in Phoenix, Arizona, stresses their work is grounded in empathy for infants and their families, sound engineering principles, and the belief that the best medical technology is the kind that helps people lead normal healthy lives.

They have announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its trademark Skylife portable phototherapy system. The device delivers a narrow band of high-intensity blue light via blue light emitting diodes (LEDs) to provide treatment for neonatal unconjugated hyperbilirubinemia (jaundice).

Infant jaundice occurs when a baby, typically a newborn, has an excess of bilirubin in its blood. This causes the child's skin to take on a "yellow" color, and often, the white's of the child's eyes will be yellow. Neonatal jaundice is a common condition, often seen in babies born before 38 weeks gestation (preterm babies). ( With agency inputs)

Ads by Google
Thursday 02 Nov 2017 12.55 PM
YOU MAY BE INTERESTED
Ads by Google
Ads by Google